NYSE$MO
Altria Group Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Altria delivered strong second-quarter results driven by tobacco businesses.
Altria reported outstanding results in the second quarter, driven by the strength of its tobacco businesses. The company has narrowed its full-year adjusted diluted EPS guidance to a range of $4.56 to $4.62, reflecting confidence in its tobacco businesses and investments in smoke-free products.
- Net revenues increased by 8.9% to $6.936 billion.
- Reported diluted EPS increased by 11.5% to $1.16.
- Adjusted diluted EPS increased by 12.8% to $1.23.
- Full-year adjusted diluted EPS guidance narrowed to $4.56 to $4.62.
Headline financials
Revenue & EPS history
Altria · Revenue · Quarterly
$5.61B
Revenue by segment
Altria · $6.74B total across 2 segments · Q2 2021
- Smokeable Products$6.05B+8.0%89.7%
- Oral Tobacco Products$693M+5.0%10.3%
Forward guidance
Altria narrows its guidance for 2021 full-year adjusted diluted EPS to be in a range of $4.56 to $4.62, representing a growth rate of 4.5% to 6% from an adjusted diluted EPS base of $4.36 in 2020. This range includes the estimated impact of the recently announced Ste. Michelle Transaction, which is expected to close in the second half of 2021.
Tailwinds
- Marketplace investments to expand the availability and awareness of Altria’s smoke-free products.
- Costs associated with building an industry-leading consumer engagement platform that enhances data collection and insights in support of ATC transition to smoke-free products
- Increased smoke-free product research and development expense.
- Continued confidence in tobacco businesses.
- Expected impact of the agreement to sale Ste. Michelle Wine Estates business.
Headwinds
- Conditions related to the economy (including unemployment rates and the impact of increased inflation).
- Fiscal stimulus.
- ATC dynamics, including stay-at-home practices, disposable income, purchasing patterns and adoption of smoke-free products.
- Regulatory and legislative (including excise tax) developments.
- The timing and extent of COVID-19 vaccine administration and the impact of COVID-19 variants.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
-0.3%
Avg return
Earnings day
-0.3%
Avg return
5 days after
+0.7%
Avg return
30 days after
47%
34 / 72 earnings
Positive
+6.7%
Q3 2024
Best reaction
-8.2%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.9% | +6.7% | +2.1% | |
| Q4 2025 | -5.2% | +1.6% | +9.4% | |
| Q3 2025 | -7.8% | -7.5% | -4.8% | |
| Q2 2025 | +3.6% | +4.3% | +13.2% | |
| Q1 2025 | +1.0% | +2.4% | +2.2% | |
| Q4 2024 | -2.1% | -0.1% | +6.1% | |
| Q3 2024 | +6.7% | +7.3% | +14.3% | |
| Q2 2024 | -1.0% | -2.4% | +6.4% | |
| Q1 2024 | +1.1% | +2.1% | +6.0% | |
| Q4 2023 | +3.1% | +1.2% | +1.8% | |
| Q3 2023 | -8.2% | -6.2% | -3.2% | |
| Q2 2023 | -1.9% | -3.1% | -2.6% | |
| Q1 2023 | +1.8% | +1.0% | -4.5% | |
| Q4 2022 | +4.3% | +4.3% | +3.3% | |
| Q3 2022 | +0.0% | -0.4% | -3.4% | |
| Q2 2022 | -0.5% | -0.5% | +4.1% | |
| Q1 2022 | +1.2% | +0.9% | -0.9% | |
| Q4 2021 | +2.0% | +2.4% | +4.1% | |
| Q3 2021 | -7.1% | -7.1% | -7.9% | |
| Q2 2021 | +0.9% | +0.4% | +4.0% | |
| Q1 2021 | +1.2% | +1.4% | +4.3% | |
| Q4 2020 | -1.8% | -0.6% | +4.3% | |
| Q3 2020 | -1.1% | +3.3% | +9.5% | |
| Q2 2020 | -1.2% | -2.3% | +3.8% | |
| Q1 2020 | -6.3% | -9.1% | -3.5% | |
| Q4 2019 | -5.1% | -7.2% | -19.4% | |
| Q3 2019 | -2.0% | +0.6% | +8.1% | |
| Q2 2019 | -6.4% | -4.7% | -12.0% | |
| Q1 2019 | -3.5% | -0.7% | -4.2% | |
| Q4 2018 | +2.9% | +2.6% | +10.4% | |
| Q3 2018 | +1.3% | +5.7% | -13.8% | |
| Q2 2018 | +0.1% | +1.4% | +1.6% | |
| Q1 2018 | +0.5% | +0.3% | -0.4% | |
| Q4 2017 | -1.3% | -5.4% | -11.1% | |
| Q3 2017 | +1.8% | +0.7% | +2.6% | |
| Q2 2017 | -6.7% | -8.7% | -10.7% | |
| Q1 2017 | -0.8% | +0.2% | +6.5% | |
| Q4 2016 | +0.4% | +0.2% | +6.2% | |
| Q3 2016 | +2.1% | +1.5% | -0.1% | |
| Q2 2016 | -1.2% | -0.4% | -3.1% | |
| Q1 2016 | +1.9% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -1.6% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | -0.1% | — | — | |
| Q4 2014 | -1.1% | — | — | |
| Q3 2014 | +1.6% | — | — | |
| Q1 2014 | +2.1% | — | — | |
| Q4 2013 | -3.3% | — | — | |
| Q3 2013 | -0.4% | — | — | |
| Q2 2013 | -3.6% | — | — | |
| Q1 2013 | +1.5% | — | — | |
| Q4 2012 | +1.5% | — | — | |
| Q3 2012 | -1.2% | — | — | |
| Q2 2012 | -0.3% | — | — | |
| Q1 2012 | -0.2% | — | — | |
| Q4 2011 | +1.4% | — | — | |
| Q3 2011 | +1.1% | — | — | |
| Q2 2011 | +0.7% | — | — | |
| Q1 2011 | -0.5% | — | — | |
| Q4 2007 | +2.7% | — | — | |
| Q4 2010 | +2.7% | — | — | |
| Q3 2010 | +1.2% | — | — | |
| Q2 2010 | -1.4% | — | — | |
| Q1 2009 | +1.2% | — | — | |
| Q1 2010 | +0.9% | — | — | |
| Q4 2009 | +2.2% | — | — | |
| Q3 2008 | -0.5% | — | — | |
| Q3 2009 | -0.5% | — | — | |
| Q4 2008 | -0.7% | — | — | |
| Q2 2009 | -0.7% | — | — | |
| Q2 2008 | -0.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro